Here is the breakdown of Q1 through Q4 2016:
● Q4 — 0.49 percent
● Q3 — 0.53 percent
● Q2 — 0.52 percent
● Q1 — 0.50 percent
Note: The data represents 208,281 ASC cataract surgery patients at 657 facilities between Oct. 1 and Dec. 31.
More articles on quality and infection control:
Rising surgical demand, increase in HAIs driving sepsis therapeutics market: 4 highlights
Theranos paying Arizona residents $4.65M, won’t operate lab for two years: 4 key notes
HAI control market to surpass $82.9B by 2020 at 8.5% CAGR: 5 key points
